Tingling Feet With Diabetes and Where ALA Therapy Fits

It often starts at night. Your toes tingle under the blanket, or your feet feel as if you are wearing socks when you are not. Some people notice burning, others notice they no longer feel the floor clearly.

• Tingling, numbness and burning in both feet are typical early signs of diabetic neuropathy.
• Symptoms usually begin in the toes and slowly move upward.
• Reduced feeling can hide cuts and blisters, which raises the risk of foot ulcers.

This article focuses on diabetes-related symptoms and alpha-lipoic acid. For a wider look at nerve pain and regenerative research, see our neuropathy guide.

Not all tingling is caused by diabetes. Other causes are common and some are easy to treat.

• Low vitamin B12, especially in people taking metformin long term.
• Thyroid problems, kidney disease and alcohol use.
• Pressure on a nerve in the back or ankle.

A foot check usually includes testing light touch with a monofilament, vibration and reflexes, along with blood tests. The American Diabetes Association recommends checking for neuropathy at diagnosis of type 2 diabetes and at least yearly afterwards.

The most reliable way to protect nerves is to address what is damaging them.

• Keep blood sugar as steady and close to target as is safe for you.
• Manage blood pressure, cholesterol and weight.
• Stop smoking and limit alcohol.
• Check your feet daily and wear well-fitting shoes.

For painful neuropathy, doctors may prescribe medicines such as duloxetine, pregabalin or gabapentin. These ease pain but do not repair nerves, so the foundation still matters.

Alpha-lipoic acid is an antioxidant involved in energy production inside cells. In diabetes, oxidative stress is thought to contribute to nerve injury, which is why ALA has been studied.

• Oral ALA is sold as a supplement, commonly in doses of 600 mg daily in studies.
• IV ALA therapy gives a supervised course of infusions over several weeks.
• It is a supportive option, not a cure, and not a replacement for diabetes treatment.

Details on how sessions run are on our ALA therapy page.

Several trials, many from Europe, found that short IV courses modestly reduced burning, pain and numbness scores in some people with diabetic neuropathy. Results for oral ALA over longer periods have been less consistent.

• Benefits reported are mostly in symptoms, not in proven nerve repair.
• The ADA position statement does not list ALA among its recommended pain treatments.
• Individual response varies, so goals and a review point should be agreed in advance.

• Check blood glucose more often during a course, especially with insulin or sulfonylureas.
• Tell your doctor about thyroid medicines and any chemotherapy.
• Ask about vitamin B1 (thiamine) status if you drink alcohol regularly.
• Report nausea, rash, dizziness or signs of low sugar during an infusion.

Urgent foot problems such as an open wound, spreading redness or swelling need prompt care. Our article on diabetic foot wounds explains why early treatment matters.

• Have other causes of my symptoms, such as B12 deficiency, been ruled out?
• How is my diabetes control, and what should change first?
• Is oral or IV ALA more appropriate for me, and for how long?
• How will we measure whether it is helping?

If you are reading about cell-based options, ask how the evidence for MSC therapy in neuropathy compares, as it remains investigational.